Teligent ROE 2010-2021 | TLGT
Current and historical return on equity (ROE) values for Teligent (TLGT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Teligent ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2021-06-30 |
$-0.09B |
$-0.04B |
162.83% |
| 2021-03-31 |
$-0.09B |
$-0.03B |
169.09% |
| 2020-12-31 |
$-0.12B |
$-0.11B |
221.82% |
| 2020-09-30 |
$-0.05B |
$-0.04B |
163.48% |
| 2020-06-30 |
$-0.05B |
$-0.04B |
282.67% |
| 2020-03-31 |
$-0.04B |
$-0.03B |
573.33% |
| 2019-12-31 |
$-0.03B |
$-0.01B |
-833.33% |
| 2019-09-30 |
$-0.03B |
$0.00B |
-388.57% |
| 2019-06-30 |
$-0.03B |
$0.01B |
-174.65% |
| 2019-03-31 |
$-0.04B |
$0.01B |
-155.34% |
| 2018-12-31 |
$-0.04B |
$0.02B |
-108.27% |
| 2018-09-30 |
$-0.03B |
$0.04B |
-70.00% |
| 2018-06-30 |
$-0.03B |
$0.04B |
-75.43% |
| 2018-03-31 |
$-0.02B |
$0.04B |
-43.30% |
| 2017-12-31 |
$-0.02B |
$0.05B |
-28.30% |
| 2017-09-30 |
$-0.01B |
$0.05B |
-25.00% |
| 2017-06-30 |
$-0.01B |
$0.06B |
-13.62% |
| 2017-03-31 |
$-0.01B |
$0.06B |
-16.60% |
| 2016-12-31 |
$-0.01B |
$0.06B |
-19.20% |
| 2016-09-30 |
$-0.01B |
$0.06B |
-20.00% |
| 2016-06-30 |
$-0.01B |
$0.06B |
-19.19% |
| 2016-03-31 |
$-0.00B |
$0.07B |
-1.42% |
| 2015-12-31 |
$0.01B |
$0.07B |
10.73% |
| 2015-09-30 |
$0.02B |
$0.07B |
32.62% |
| 2015-06-30 |
$0.02B |
$0.08B |
45.60% |
| 2015-03-31 |
$0.01B |
$0.05B |
41.27% |
| 2014-12-31 |
$0.01B |
$0.04B |
27.27% |
| 2014-09-30 |
$-0.00B |
$0.03B |
-7.14% |
| 2014-06-30 |
$-0.00B |
$0.01B |
-13.79% |
| 2014-03-31 |
$-0.00B |
$0.01B |
-14.81% |
| 2013-12-31 |
$-0.00B |
$0.01B |
-16.00% |
| 2013-09-30 |
$-0.00B |
$0.01B |
-16.67% |
| 2013-06-30 |
$-0.00B |
$0.01B |
-34.78% |
| 2013-03-31 |
$-0.00B |
$0.01B |
-50.00% |
| 2012-12-31 |
$-0.00B |
$0.01B |
-64.00% |
| 2012-09-30 |
$-0.00B |
$0.01B |
-59.26% |
| 2012-06-30 |
$-0.00B |
$0.01B |
-40.00% |
| 2012-03-31 |
$-0.00B |
$0.01B |
-37.50% |
| 2011-12-31 |
$-0.00B |
$0.01B |
-35.29% |
| 2011-09-30 |
$-0.00B |
$0.01B |
-33.33% |
| 2011-06-30 |
$-0.01B |
$0.01B |
-62.50% |
| 2011-03-31 |
$-0.01B |
$0.01B |
-71.43% |
| 2010-12-31 |
$-0.01B |
$0.01B |
-80.00% |
| 2010-09-30 |
$-0.01B |
$0.00B |
-100.00% |
| 2010-06-30 |
$-0.00B |
$0.01B |
-72.73% |
| 2010-03-31 |
$-0.01B |
$0.01B |
-116.67% |
| 2009-12-31 |
$-0.01B |
$0.01B |
-145.45% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
